# 2026-06064: FDA Speeds Up TB Test Approvals in Rule Tweak

2026-06064, Microbiology Devices; Reclassification of Mycobacterium Tuberculosis Cell-Mediated Immunity Tests and Immune Response Enzyme-Linked Immunospot Tests, is a Federal Register proposed rule from Health and Human Services Department, Food and Drug Administration published 2026-03-30, effective Submit electronic or written comments on the proposed order by May 29, 2026. Please see section X of this document for the proposed effective date when the new requirements would apply and for the proposed effective date of a final order based on this proposed order. (as of 2026-06-11).

- Canonical: https://policyrisk.com/federal-register/2026-06064
- As of: 2026-06-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-06064
- Title: Microbiology Devices; Reclassification of Mycobacterium Tuberculosis Cell-Mediated Immunity Tests and Immune Response Enzyme-Linked Immunospot Tests
- Type: Proposed Rule
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 15572
- Published: 2026-03-30
- Effective: Submit electronic or written comments on the proposed order by May 29, 2026. Please see section X of this document for the proposed effective date when the new requirements would apply and for the proposed effective date of a final order based on this proposed order.
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-11

## In one line

FDA Speeds Up TB Test Approvals in Rule Tweak

## Summary

The FDA is planning to change the rules for certain tuberculosis (TB) tests, making them easier to get approved by moving them from a strict category to a more flexible one. This affects companies that make these TB immunity tests, helping speed up their review while keeping safety in check. Comments on this change are open until May 29, 2026, so stakeholders have time to weigh in before the new rules kick in.

## Abstract

The Food and Drug Administration (FDA) is proposing to reclassify Mycobacterium tuberculosis cell-mediated immunity tests and Mycobacterium tuberculosis cell-mediated immune response enzyme-linked immunospot tests intended for use as an aid in the diagnosis of Mycobacterium tuberculosis infection (product codes NCD and OJN, respectively), both of which are postamendments class III devices (premarket approval), into class II (special controls), subject to premarket notification. FDA is also proposing a new device classification regulation along with the special controls that FDA believes are necessary to provide a reasonable assurance of safety and effectiveness for these devices.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-06064 on federalregister.gov](https://www.federalregister.gov/documents/2026/03/30/2026-06064/microbiology-devices-reclassification-of-mycobacterium-tuberculosis-cell-mediated-immunity-tests-and)
- [2026-06064 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-03-30/pdf/2026-06064.pdf)

## Related
- [Previous: 2026-06017, Improving Wage Protections for the Temporary and Permanent Employment of Certai…](https://policyrisk.com/federal-register/2026-06017)
- [Next: 2026-06066, Reporting Deadline Extension for the Health and Safety Data Reporting Rule Unde…](https://policyrisk.com/federal-register/2026-06066)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-06064 (as of 2026-06-11).
